All sites C00-96,D32-33,D42-43,D45-47,D76 654 92.2 2.0 2.5 0.7 2.6
Mouth, pharynx C00-14 7 97.3 - - 2.7 -
  Lip C00 0 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 75.0 - - 25.0 -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 122 84.6 2.0 7.2 1.5 4.7
  Oesophagus C15 3 93.8 - 6.3 - -
  Stomach C16 10 96.2 - 3.8 - -
  Small intestine C17 3 100.0 - - - -
  Colon C18 39 92.3 - 4.1 0.5 3.1
  Rectum, rectosigmoid C19-20 21 97.2 - - 0.9 1.9
  Anus C21 2 75.0 12.5 - 12.5 -
  Liver C22 8 90.2 - 4.9 4.9 -
  Gallbladder, bile ducts C23-24 8 72.5 - 15.0 - 12.5
  Pancreas C25 26 59.4 8.6 19.5 2.3 10.2
  Other digestive organs C26 2 66.7 - - 8.3 25.0
Respiratory organs C30-39 33 85.3 7.4 3.7 0.6 3.1
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 31 86.5 7.7 2.6 0.6 2.6
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 25 100.0 - - - -
Skin, non-melanoma C44 38 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 5 96.0 - - - 4.0
Breast C50 204 99.2 0.3 0.1 0.2 0.2
Female genital organs C51-58 72 96.1 1.4 0.8 0.8 0.8
  Cervix uteri C53 6 96.6 - 3.4 - -
  Corpus uteri C54 37 100.0 - - - -
  Uterus, other C55,C58 0 - - - - 100.0
  Ovary C56 18 87.5 5.7 1.1 3.4 2.3
  Other female genital C51-52,C57 11 98.1 - 1.9 - -
Urinary organs C64-68 33 92.7 - 3.0 1.8 2.4
  Kidney C64 20 89.1 - 5.0 2.0 4.0
  Bladder and urinary tract2 C65-68 13 98.4 - - 1.6 -
Eye C69 1 33.3 - 66.7 - -
Brain, central nervous system C70-72,D32-33,D42-43 25 86.3 - 8.1 - 5.6
Thyroid gland C73 14 97.2 2.8 - - -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 15 68.5 9.6 9.6 2.7 9.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 57 79.7 8.7 1.4 1.0 9.1
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 25 99.2 - - 0.8 -
  Malignant immunoproliferative diseases C88 1 33.3 33.3 - - 33.3
  Myeloma and other plasma cell tumors C90 10 58.3 10.4 8.3 2.1 20.8
  Leukaemia C91-95 15 69.3 21.3 - 1.3 8.0
  Myelodysplastic syndromes D46 3 53.3 13.3 - - 33.3
  Myeloproliferaitive neoplasms D45,D47 3 64.3 7.1 - - 28.6
Not included above
  Carcinoma in situ of the breast D05 15 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 43 100.0 - - - -
  Borderline tumour of the ovary D39 9 97.8 - 2.2 - -
  Basal cell carcinoma of the skin 209 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.